nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—HTR2C—Sorafenib—liver cancer	0.383	0.559	CbGbCtD
Prochlorperazine—CYP2D6—Sorafenib—liver cancer	0.115	0.168	CbGbCtD
Prochlorperazine—CYP3A4—Sorafenib—liver cancer	0.073	0.107	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—liver cancer	0.0697	0.102	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—liver cancer	0.0443	0.0647	CbGbCtD
Prochlorperazine—Abnormal pigmentation—Epirubicin—liver cancer	0.0205	0.0719	CcSEcCtD
Prochlorperazine—Abnormal pigmentation—Doxorubicin—liver cancer	0.019	0.0666	CcSEcCtD
Prochlorperazine—Embolism venous—Sorafenib—liver cancer	0.0104	0.0364	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0072	0.0252	CcSEcCtD
Prochlorperazine—Venous thromboembolism—Epirubicin—liver cancer	0.00659	0.0231	CcSEcCtD
Prochlorperazine—Venous thromboembolism—Doxorubicin—liver cancer	0.00609	0.0214	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Epirubicin—liver cancer	0.0058	0.0203	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Doxorubicin—liver cancer	0.00537	0.0188	CcSEcCtD
Prochlorperazine—Gynaecomastia—Sorafenib—liver cancer	0.00469	0.0164	CcSEcCtD
Prochlorperazine—Eczema—Sorafenib—liver cancer	0.00423	0.0148	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00403	0.0141	CcSEcCtD
Prochlorperazine—Embolism venous—Epirubicin—liver cancer	0.00384	0.0134	CcSEcCtD
Prochlorperazine—Embolism venous—Doxorubicin—liver cancer	0.00355	0.0124	CcSEcCtD
Prochlorperazine—Dysphagia—Sorafenib—liver cancer	0.00329	0.0115	CcSEcCtD
Prochlorperazine—Eruption—Epirubicin—liver cancer	0.00315	0.011	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Sorafenib—liver cancer	0.00303	0.0106	CcSEcCtD
Prochlorperazine—Eruption—Doxorubicin—liver cancer	0.00291	0.0102	CcSEcCtD
Prochlorperazine—Jaundice—Sorafenib—liver cancer	0.00286	0.01	CcSEcCtD
Prochlorperazine—Erythema multiforme—Sorafenib—liver cancer	0.00249	0.00871	CcSEcCtD
Prochlorperazine—Glycosuria—Epirubicin—liver cancer	0.00239	0.00837	CcSEcCtD
Prochlorperazine—Arrhythmia—Sorafenib—liver cancer	0.00235	0.00823	CcSEcCtD
Prochlorperazine—Blood disorder—Epirubicin—liver cancer	0.00232	0.00812	CcSEcCtD
Prochlorperazine—Liver injury—Epirubicin—liver cancer	0.0023	0.00806	CcSEcCtD
Prochlorperazine—Erythema—Sorafenib—liver cancer	0.00229	0.00802	CcSEcCtD
Prochlorperazine—Glycosuria—Doxorubicin—liver cancer	0.00221	0.00775	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Epirubicin—liver cancer	0.0022	0.00772	CcSEcCtD
Prochlorperazine—Amenorrhoea—Epirubicin—liver cancer	0.0022	0.00772	CcSEcCtD
Prochlorperazine—Muscle spasms—Sorafenib—liver cancer	0.0022	0.00771	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—liver cancer	0.00214	0.00751	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—liver cancer	0.00213	0.00746	CcSEcCtD
Prochlorperazine—Angioedema—Sorafenib—liver cancer	0.00209	0.00733	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—liver cancer	0.00206	0.00722	CcSEcCtD
Prochlorperazine—Leukopenia—Sorafenib—liver cancer	0.00205	0.00718	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—liver cancer	0.00204	0.00714	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—liver cancer	0.00204	0.00714	CcSEcCtD
Prochlorperazine—Cough—Sorafenib—liver cancer	0.002	0.007	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—liver cancer	0.00198	0.00695	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—liver cancer	0.00194	0.00678	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—liver cancer	0.00194	0.00678	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—liver cancer	0.00191	0.0067	CcSEcCtD
Prochlorperazine—Dry mouth—Sorafenib—liver cancer	0.00191	0.00668	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—liver cancer	0.00191	0.00668	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Sorafenib—liver cancer	0.00187	0.00655	CcSEcCtD
Prochlorperazine—Infection—Sorafenib—liver cancer	0.00186	0.00651	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—liver cancer	0.00184	0.00643	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Sorafenib—liver cancer	0.00183	0.00641	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—liver cancer	0.00182	0.00637	CcSEcCtD
Prochlorperazine—Skin disorder—Sorafenib—liver cancer	0.00182	0.00636	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—liver cancer	0.00179	0.00628	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—liver cancer	0.00179	0.00628	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—liver cancer	0.00177	0.0062	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—liver cancer	0.00177	0.0062	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—liver cancer	0.00168	0.00589	CcSEcCtD
Prochlorperazine—Dyspnoea—Sorafenib—liver cancer	0.00167	0.00584	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—liver cancer	0.00164	0.00573	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—liver cancer	0.0016	0.00561	CcSEcCtD
Prochlorperazine—Constipation—Sorafenib—liver cancer	0.0016	0.0056	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—liver cancer	0.00156	0.00548	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—liver cancer	0.0015	0.00524	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—liver cancer	0.00149	0.00522	CcSEcCtD
Prochlorperazine—Urticaria—Sorafenib—liver cancer	0.00148	0.0052	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—liver cancer	0.00148	0.00519	CcSEcCtD
Prochlorperazine—Body temperature increased—Sorafenib—liver cancer	0.00148	0.00518	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00145	0.00509	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—liver cancer	0.00145	0.00507	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—liver cancer	0.00144	0.00505	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—liver cancer	0.00138	0.00485	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00138	0.00483	CcSEcCtD
Prochlorperazine—Hypersensitivity—Sorafenib—liver cancer	0.00138	0.00482	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00134	0.00471	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—liver cancer	0.00134	0.00468	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—liver cancer	0.00133	0.00467	CcSEcCtD
Prochlorperazine—Pruritus—Sorafenib—liver cancer	0.00132	0.00463	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—liver cancer	0.00124	0.00433	CcSEcCtD
Prochlorperazine—Dizziness—Sorafenib—liver cancer	0.00124	0.00433	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—liver cancer	0.00121	0.00426	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—liver cancer	0.00121	0.00426	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—liver cancer	0.00121	0.00426	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—liver cancer	0.0012	0.00421	CcSEcCtD
Prochlorperazine—Rash—Sorafenib—liver cancer	0.00118	0.00413	CcSEcCtD
Prochlorperazine—Dermatitis—Sorafenib—liver cancer	0.00118	0.00412	CcSEcCtD
Prochlorperazine—Headache—Sorafenib—liver cancer	0.00117	0.0041	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—liver cancer	0.00115	0.00404	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—liver cancer	0.00112	0.00394	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—liver cancer	0.00112	0.00394	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—liver cancer	0.00112	0.00394	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—liver cancer	0.00111	0.0039	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—liver cancer	0.00111	0.00388	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—liver cancer	0.00111	0.00387	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—liver cancer	0.0011	0.00384	CcSEcCtD
Prochlorperazine—Clomipramine—GSTP1—liver cancer	0.00109	0.159	CrCbGaD
Prochlorperazine—Drowsiness—Epirubicin—liver cancer	0.00108	0.00379	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—liver cancer	0.00107	0.00374	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—liver cancer	0.00106	0.0037	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00103	0.00359	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—liver cancer	0.00102	0.00358	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—liver cancer	0.00101	0.00355	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—liver cancer	0.00101	0.00354	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—liver cancer	0.001	0.00351	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—liver cancer	0.000977	0.00342	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—liver cancer	0.000958	0.00336	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—liver cancer	0.000935	0.00328	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—liver cancer	0.000919	0.00322	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—liver cancer	0.000886	0.0031	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—liver cancer	0.000868	0.00304	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—liver cancer	0.00085	0.00298	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—liver cancer	0.000846	0.00297	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—liver cancer	0.000822	0.00288	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—liver cancer	0.000814	0.00285	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—liver cancer	0.000804	0.00282	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—liver cancer	0.000798	0.00279	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—liver cancer	0.000783	0.00274	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—liver cancer	0.000778	0.00272	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—liver cancer	0.000761	0.00266	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—liver cancer	0.000757	0.00265	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—liver cancer	0.000753	0.00264	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—liver cancer	0.000738	0.00259	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—liver cancer	0.000738	0.00259	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—liver cancer	0.000733	0.00257	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—liver cancer	0.00072	0.00252	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—liver cancer	0.000705	0.00247	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—liver cancer	0.000701	0.00246	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—liver cancer	0.000691	0.00242	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—liver cancer	0.000691	0.00242	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—liver cancer	0.000686	0.0024	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—liver cancer	0.000683	0.00239	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—liver cancer	0.000678	0.00238	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—liver cancer	0.000676	0.00237	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—liver cancer	0.000671	0.00235	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—liver cancer	0.000652	0.00228	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—liver cancer	0.000645	0.00226	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—liver cancer	0.000639	0.00224	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—liver cancer	0.000639	0.00224	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—liver cancer	0.000635	0.00222	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—liver cancer	0.000626	0.00219	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—liver cancer	0.000625	0.00219	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—liver cancer	0.000621	0.00217	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—liver cancer	0.000616	0.00216	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—liver cancer	0.000614	0.00215	CcSEcCtD
Prochlorperazine—Fluphenazine—CYP2E1—liver cancer	0.000612	0.0893	CrCbGaD
Prochlorperazine—Hypotension—Doxorubicin—liver cancer	0.000597	0.00209	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—liver cancer	0.000591	0.00207	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—liver cancer	0.000578	0.00203	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—liver cancer	0.00057	0.002	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—liver cancer	0.000568	0.00199	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—liver cancer	0.000549	0.00192	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—liver cancer	0.000546	0.00191	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—liver cancer	0.000546	0.00191	CcSEcCtD
Prochlorperazine—Thioridazine—CYP2E1—liver cancer	0.000527	0.0769	CrCbGaD
Prochlorperazine—Hypersensitivity—Epirubicin—liver cancer	0.000509	0.00178	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—liver cancer	0.000508	0.00178	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—liver cancer	0.000505	0.00177	CcSEcCtD
Prochlorperazine—Methotrimeprazine—CYP2E1—liver cancer	0.000503	0.0734	CrCbGaD
Prochlorperazine—Pruritus—Epirubicin—liver cancer	0.000489	0.00171	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—liver cancer	0.000471	0.00165	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—liver cancer	0.000457	0.0016	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—liver cancer	0.000452	0.00158	CcSEcCtD
Prochlorperazine—Desipramine—CYP2E1—liver cancer	0.00045	0.0657	CrCbGaD
Prochlorperazine—Rash—Epirubicin—liver cancer	0.000435	0.00153	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—liver cancer	0.000435	0.00152	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—liver cancer	0.000433	0.00152	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—liver cancer	0.000423	0.00148	CcSEcCtD
Prochlorperazine—Clozapine—CYP2E1—liver cancer	0.000408	0.0595	CrCbGaD
Prochlorperazine—Acepromazine—ALB—liver cancer	0.000405	0.059	CrCbGaD
Prochlorperazine—Rash—Doxorubicin—liver cancer	0.000403	0.00141	CcSEcCtD
Prochlorperazine—Clozapine—CYP1A1—liver cancer	0.000403	0.0587	CrCbGaD
Prochlorperazine—Dermatitis—Doxorubicin—liver cancer	0.000403	0.00141	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—liver cancer	0.0004	0.0014	CcSEcCtD
Prochlorperazine—Thioproperazine—ALB—liver cancer	0.000395	0.0577	CrCbGaD
Prochlorperazine—Thiothixene—ALB—liver cancer	0.000389	0.0567	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—liver cancer	0.000389	0.0567	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP2E1—liver cancer	0.000384	0.056	CrCbGaD
Prochlorperazine—Imipramine—CYP2E1—liver cancer	0.000382	0.0557	CrCbGaD
Prochlorperazine—Clomipramine—ALB—liver cancer	0.000307	0.0449	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—liver cancer	0.000211	0.0308	CrCbGaD
Prochlorperazine—DRD2—Signaling by GPCR—RAF1—liver cancer	8.73e-06	0.000383	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GOT2—liver cancer	8.66e-06	0.00038	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—H2AFX—liver cancer	8.62e-06	0.000378	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—IL2—liver cancer	8.62e-06	0.000378	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CSF2—liver cancer	8.59e-06	0.000376	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CG—liver cancer	8.58e-06	0.000376	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—APC—liver cancer	8.58e-06	0.000376	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RAF1—liver cancer	8.57e-06	0.000376	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTA2—liver cancer	8.56e-06	0.000375	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CB—liver cancer	8.52e-06	0.000373	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—H2AFX—liver cancer	8.46e-06	0.000371	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—IL2—liver cancer	8.46e-06	0.000371	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CSF2—liver cancer	8.45e-06	0.00037	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RAF1—liver cancer	8.43e-06	0.00037	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	8.36e-06	0.000367	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—H2AFX—liver cancer	8.33e-06	0.000365	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—IL2—liver cancer	8.32e-06	0.000365	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTA1—liver cancer	8.26e-06	0.000362	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	8.23e-06	0.000361	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NAT2—liver cancer	8.17e-06	0.000358	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP2E1—liver cancer	8.14e-06	0.000357	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KDR—liver cancer	8.08e-06	0.000354	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—BRAF—liver cancer	8.07e-06	0.000354	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK14—liver cancer	8.02e-06	0.000352	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ESR1—liver cancer	7.87e-06	0.000345	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALDOB—liver cancer	7.83e-06	0.000343	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL2—liver cancer	7.82e-06	0.000343	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TERT—liver cancer	7.79e-06	0.000342	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—F2—liver cancer	7.78e-06	0.000341	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL2—liver cancer	7.68e-06	0.000337	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TERT—liver cancer	7.65e-06	0.000336	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYCS—liver cancer	7.62e-06	0.000334	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL2—liver cancer	7.56e-06	0.000331	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CD—liver cancer	7.55e-06	0.000331	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TERT—liver cancer	7.53e-06	0.00033	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GOT1—liver cancer	7.47e-06	0.000328	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GGT1—liver cancer	7.47e-06	0.000328	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PIK3CA—liver cancer	7.47e-06	0.000328	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CRABP1—liver cancer	7.47e-06	0.000328	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SERPINE1—liver cancer	7.46e-06	0.000327	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APC—liver cancer	7.44e-06	0.000326	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CG—liver cancer	7.44e-06	0.000326	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—KRAS—liver cancer	7.39e-06	0.000324	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KDR—liver cancer	7.13e-06	0.000313	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK14—liver cancer	7.08e-06	0.000311	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KDR—liver cancer	7e-06	0.000307	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BRAF—liver cancer	6.99e-06	0.000307	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK14—liver cancer	6.95e-06	0.000305	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ESR1—liver cancer	6.95e-06	0.000305	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KDR—liver cancer	6.89e-06	0.000302	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—F2—liver cancer	6.86e-06	0.000301	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK14—liver cancer	6.84e-06	0.0003	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ESR1—liver cancer	6.82e-06	0.000299	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PIK3CA—liver cancer	6.79e-06	0.000298	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—F2—liver cancer	6.74e-06	0.000295	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAF1—liver cancer	6.74e-06	0.000295	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTP1—liver cancer	6.71e-06	0.000294	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ESR1—liver cancer	6.71e-06	0.000294	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—F2—liver cancer	6.63e-06	0.000291	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMOX1—liver cancer	6.62e-06	0.00029	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MTOR—liver cancer	6.58e-06	0.000288	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CB—liver cancer	6.58e-06	0.000288	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—liver cancer	6.57e-06	0.000288	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APC—liver cancer	6.57e-06	0.000288	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CD—liver cancer	6.54e-06	0.000287	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HPGDS—liver cancer	6.53e-06	0.000286	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—liver cancer	6.48e-06	0.000284	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SERPINE1—liver cancer	6.47e-06	0.000284	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APC—liver cancer	6.45e-06	0.000283	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—liver cancer	6.45e-06	0.000283	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—liver cancer	6.4e-06	0.000281	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	6.34e-06	0.000278	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APC—liver cancer	6.34e-06	0.000278	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRAS—liver cancer	6.28e-06	0.000275	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—liver cancer	6.17e-06	0.000271	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1B—liver cancer	6.17e-06	0.000271	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—liver cancer	6.17e-06	0.000271	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—liver cancer	6.11e-06	0.000268	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—liver cancer	6.06e-06	0.000266	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—liver cancer	6.05e-06	0.000265	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—liver cancer	6.04e-06	0.000265	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—liver cancer	6.01e-06	0.000263	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—liver cancer	5.96e-06	0.000261	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—liver cancer	5.89e-06	0.000258	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—liver cancer	5.88e-06	0.000258	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—JUN—liver cancer	5.88e-06	0.000258	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A1—liver cancer	5.85e-06	0.000256	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAF1—liver cancer	5.84e-06	0.000256	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—liver cancer	5.83e-06	0.000256	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PSMD10—liver cancer	5.82e-06	0.000255	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PSMA4—liver cancer	5.82e-06	0.000255	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—liver cancer	5.77e-06	0.000253	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	5.72e-06	0.000251	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—liver cancer	5.72e-06	0.000251	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—liver cancer	5.71e-06	0.00025	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MTOR—liver cancer	5.7e-06	0.00025	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—liver cancer	5.7e-06	0.00025	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1A—liver cancer	5.7e-06	0.00025	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—liver cancer	5.67e-06	0.000249	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GOT2—liver cancer	5.66e-06	0.000248	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—liver cancer	5.65e-06	0.000248	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	5.61e-06	0.000246	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—liver cancer	5.61e-06	0.000246	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	5.58e-06	0.000245	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK8—liver cancer	5.56e-06	0.000244	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—liver cancer	5.55e-06	0.000243	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—liver cancer	5.54e-06	0.000243	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	5.52e-06	0.000242	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	5.52e-06	0.000242	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—liver cancer	5.46e-06	0.000239	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—liver cancer	5.45e-06	0.000239	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRAS—liver cancer	5.44e-06	0.000239	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1B—liver cancer	5.35e-06	0.000235	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARA—liver cancer	5.35e-06	0.000235	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2E1—liver cancer	5.32e-06	0.000233	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—liver cancer	5.29e-06	0.000232	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—liver cancer	5.24e-06	0.00023	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—liver cancer	5.24e-06	0.00023	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—liver cancer	5.21e-06	0.000228	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	5.19e-06	0.000228	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAF1—liver cancer	5.15e-06	0.000226	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—liver cancer	5.13e-06	0.000225	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—liver cancer	5.1e-06	0.000224	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	5.1e-06	0.000224	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—JUN—liver cancer	5.09e-06	0.000223	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—liver cancer	5.08e-06	0.000223	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAF1—liver cancer	5.06e-06	0.000222	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—liver cancer	5.06e-06	0.000222	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MTOR—liver cancer	5.03e-06	0.000221	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—liver cancer	5.03e-06	0.000221	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	5.02e-06	0.00022	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYCS—liver cancer	4.98e-06	0.000218	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAF1—liver cancer	4.98e-06	0.000218	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—liver cancer	4.96e-06	0.000217	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MTOR—liver cancer	4.94e-06	0.000217	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—liver cancer	4.94e-06	0.000217	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1A—liver cancer	4.94e-06	0.000217	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GOT1—liver cancer	4.89e-06	0.000214	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GGT1—liver cancer	4.89e-06	0.000214	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	4.86e-06	0.000213	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MTOR—liver cancer	4.86e-06	0.000213	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK8—liver cancer	4.82e-06	0.000211	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—liver cancer	4.81e-06	0.000211	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRAS—liver cancer	4.8e-06	0.000211	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—liver cancer	4.72e-06	0.000207	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1B—liver cancer	4.72e-06	0.000207	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRAS—liver cancer	4.72e-06	0.000207	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—liver cancer	4.71e-06	0.000207	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—liver cancer	4.67e-06	0.000205	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRAS—liver cancer	4.64e-06	0.000204	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1B—liver cancer	4.64e-06	0.000203	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—liver cancer	4.63e-06	0.000203	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—liver cancer	4.62e-06	0.000203	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—liver cancer	4.6e-06	0.000202	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—liver cancer	4.59e-06	0.000201	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.58e-06	0.000201	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	4.56e-06	0.0002	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—liver cancer	4.54e-06	0.000199	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—liver cancer	4.54e-06	0.000199	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—liver cancer	4.51e-06	0.000198	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	4.51e-06	0.000198	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—liver cancer	4.51e-06	0.000198	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—JUN—liver cancer	4.5e-06	0.000197	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—liver cancer	4.47e-06	0.000196	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—liver cancer	4.46e-06	0.000196	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—liver cancer	4.46e-06	0.000196	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—liver cancer	4.45e-06	0.000195	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—liver cancer	4.44e-06	0.000195	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—liver cancer	4.42e-06	0.000194	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—liver cancer	4.42e-06	0.000194	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—JUN—liver cancer	4.41e-06	0.000194	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—liver cancer	4.41e-06	0.000193	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—liver cancer	4.39e-06	0.000192	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—liver cancer	4.38e-06	0.000192	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—liver cancer	4.37e-06	0.000192	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—liver cancer	4.36e-06	0.000191	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1A—liver cancer	4.36e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—liver cancer	4.35e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—JUN—liver cancer	4.34e-06	0.00019	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMOX1—liver cancer	4.33e-06	0.00019	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	4.31e-06	0.000189	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—liver cancer	4.29e-06	0.000188	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1A—liver cancer	4.28e-06	0.000188	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK8—liver cancer	4.25e-06	0.000187	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—liver cancer	4.24e-06	0.000186	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—liver cancer	4.23e-06	0.000185	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	4.21e-06	0.000185	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK8—liver cancer	4.18e-06	0.000183	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—liver cancer	4.17e-06	0.000183	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK8—liver cancer	4.11e-06	0.00018	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—liver cancer	4.1e-06	0.00018	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—liver cancer	4.09e-06	0.00018	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—liver cancer	4.08e-06	0.000179	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—liver cancer	4.03e-06	0.000177	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.03e-06	0.000177	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—liver cancer	4.01e-06	0.000176	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—liver cancer	3.98e-06	0.000174	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—liver cancer	3.93e-06	0.000172	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—liver cancer	3.89e-06	0.000171	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—liver cancer	3.88e-06	0.00017	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—liver cancer	3.86e-06	0.000169	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.82e-06	0.000168	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—liver cancer	3.82e-06	0.000167	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—liver cancer	3.79e-06	0.000166	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—liver cancer	3.78e-06	0.000166	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—liver cancer	3.76e-06	0.000165	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRAS—liver cancer	3.71e-06	0.000163	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—liver cancer	3.61e-06	0.000158	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—liver cancer	3.6e-06	0.000158	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—liver cancer	3.57e-06	0.000156	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—liver cancer	3.55e-06	0.000156	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—liver cancer	3.55e-06	0.000156	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—liver cancer	3.54e-06	0.000155	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.51e-06	0.000154	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARA—liver cancer	3.5e-06	0.000153	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—liver cancer	3.49e-06	0.000153	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—liver cancer	3.48e-06	0.000153	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	3.48e-06	0.000152	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—liver cancer	3.36e-06	0.000147	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—liver cancer	3.34e-06	0.000146	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—liver cancer	3.28e-06	0.000144	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—liver cancer	3.28e-06	0.000144	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—liver cancer	3.23e-06	0.000141	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRAS—liver cancer	3.22e-06	0.000141	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—liver cancer	3.08e-06	0.000135	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—liver cancer	3.07e-06	0.000134	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—liver cancer	3.01e-06	0.000132	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—liver cancer	3e-06	0.000131	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—liver cancer	2.97e-06	0.00013	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.96e-06	0.00013	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—liver cancer	2.91e-06	0.000128	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—liver cancer	2.89e-06	0.000127	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—liver cancer	2.87e-06	0.000126	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—liver cancer	2.84e-06	0.000124	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRAS—liver cancer	2.84e-06	0.000124	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRAS—liver cancer	2.79e-06	0.000122	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRAS—liver cancer	2.74e-06	0.00012	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—liver cancer	2.72e-06	0.000119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—liver cancer	2.67e-06	0.000117	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.63e-06	0.000115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—liver cancer	2.62e-06	0.000115	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—liver cancer	2.6e-06	0.000114	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—liver cancer	2.51e-06	0.00011	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—liver cancer	2.46e-06	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—liver cancer	2.42e-06	0.000106	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.3e-06	0.000101	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.14e-06	9.38e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—liver cancer	1.75e-06	7.66e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.4e-06	6.13e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—liver cancer	1.14e-06	5.01e-05	CbGpPWpGaD
